Therapeutic Innovation Australia
Overview
Therapeutic Innovation Australia is a not-for-profit, government-funded consortium that accelerates the translation of medical research by providing access to infrastructure and awarding grants for therapeutic development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| GlyTherix Ltd | Mar 2021 | Grant | Lead |
| Aculeus Therapeutics | Jul 2021 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Therapeutic Innovation Australia based?
Therapeutic Innovation Australia is headquartered in Woolloongabba, Australia.
When was Therapeutic Innovation Australia founded?
Therapeutic Innovation Australia was founded in 2008.
How many portfolio companies does Therapeutic Innovation Australia have?
Therapeutic Innovation Australia has 2 portfolio companies in Caplight's dataset.
What are some companies in Therapeutic Innovation Australia's portfolio?
Portfolio companies visible on Caplight include GlyTherix Ltd, Aculeus Therapeutics.
What was Therapeutic Innovation Australia's most recent investment shown here?
Therapeutic Innovation Australia's most recent investment in this portfolio sample was in Aculeus Therapeutics in 2021.
What sectors does Therapeutic Innovation Australia focus on?
Therapeutic Innovation Australia focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Therapeutic Innovation Australia focus on?
Stage focus information for Therapeutic Innovation Australia is not publicly available.